Induction of ERBB2 Nuclear Transport after Radiation in Breast Cancer Cells

The ERBB2 nuclear transport in breast cancer cell lines after radiation and its possible role in radiation tolerance were observed. Confocal microscopy and Western blotting were applied to detect the nuclear ERBB2 expression after radiation in breast carcinomas cells. And the effects of Herceptin, A...

Full description

Saved in:
Bibliographic Details
Published inJournal of Huazhong University of Science and Technology. Medical sciences Vol. 29; no. 3; pp. 350 - 353
Main Author 罗波 于世英 庄亮 夏曙 赵臻 荣磊
Format Journal Article
LanguageEnglish
Published Heidelberg Huazhong University of Science and Technology 01.06.2009
Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China
Subjects
Online AccessGet full text
ISSN1672-0733
1993-1352
DOI10.1007/s11596-009-0317-8

Cover

Abstract The ERBB2 nuclear transport in breast cancer cell lines after radiation and its possible role in radiation tolerance were observed. Confocal microscopy and Western blotting were applied to detect the nuclear ERBB2 expression after radiation in breast carcinomas cells. And the effects of Herceptin, AG825 and Cisplatin on the expression of nuclear ERBB2 were investigated. Survival fractions were also observed. After radiation, compared with control group, confocal microscopy and Western blot revealed that the expression of nuclear ERBB2 was increased in breast cancer cells time-dependently. Herceptin, and AG825 could significantly inhibit the radiation-induced nuclear ERBB2 expression, and decrease survival fractions. Cisplatin also induced the nuclear ERBB2 expression in breast cancer cells with high ERBB2 expression. It was concluded that radiation could induce ERBB2 nuclear transport, and nuclear ERBB2 may correlate with radiation resistance in breast cancer cells with high ERBB2 expression.
AbstractList R5; ex-pression in breast cancer cells with high ERBB2 expression. It was concluded that radiation could induce ERBB2 nuclear transport, and nuclear ERBB2 may correlate with radiation resistance in breast cancer cells with high ERBB2 expression.
The ERBB2 nuclear transport in breast cancer cell lines after radiation and its possible role in radiation tolerance were observed. Confocal microscopy and Western blotting were applied to detect the nuclear ERBB2 expression after radiation in breast carcinomas cells. And the effects of Herceptin, AG825 and Cisplatin on the expression of nuclear ERBB2 were investigated. Survival fractions were also observed. After radiation, compared with control group, confocal microscopy and Western blot revealed that the expression of nuclear ERBB2 was increased in breast cancer cells time-dependently. Herceptin, and AG825 could significantly inhibit the radiation-induced nuclear ERBB2 expression, and decrease survival fractions. Cisplatin also induced the nuclear ERBB2 expression in breast cancer cells with high ERBB2 expression. It was concluded that radiation could induce ERBB2 nuclear transport, and nuclear ERBB2 may correlate with radiation resistance in breast cancer cells with high ERBB2 expression.The ERBB2 nuclear transport in breast cancer cell lines after radiation and its possible role in radiation tolerance were observed. Confocal microscopy and Western blotting were applied to detect the nuclear ERBB2 expression after radiation in breast carcinomas cells. And the effects of Herceptin, AG825 and Cisplatin on the expression of nuclear ERBB2 were investigated. Survival fractions were also observed. After radiation, compared with control group, confocal microscopy and Western blot revealed that the expression of nuclear ERBB2 was increased in breast cancer cells time-dependently. Herceptin, and AG825 could significantly inhibit the radiation-induced nuclear ERBB2 expression, and decrease survival fractions. Cisplatin also induced the nuclear ERBB2 expression in breast cancer cells with high ERBB2 expression. It was concluded that radiation could induce ERBB2 nuclear transport, and nuclear ERBB2 may correlate with radiation resistance in breast cancer cells with high ERBB2 expression.
The ERBB2 nuclear transport in breast cancer cell lines after radiation and its possible role in radiation tolerance were observed. Confocal microscopy and Western blotting were applied to detect the nuclear ERBB2 expression after radiation in breast carcinomas cells. And the effects of Herceptin, AG825 and Cisplatin on the expression of nuclear ERBB2 were investigated. Survival fractions were also observed. After radiation, compared with control group, confocal microscopy and Western blot revealed that the expression of nuclear ERBB2 was increased in breast cancer cells time-dependently. Herceptin, and AG825 could significantly inhibit the radiation-induced nuclear ERBB2 expression, and decrease survival fractions. Cisplatin also induced the nuclear ERBB2 expression in breast cancer cells with high ERBB2 expression. It was concluded that radiation could induce ERBB2 nuclear transport, and nuclear ERBB2 may correlate with radiation resistance in breast cancer cells with high ERBB2 expression.
Summary The ERBB2 nuclear transport in breast cancer cell lines after radiation and its possible role in radiation tolerance were observed. Confocal microscopy and Western blotting were applied to detect the nuclear ERBB2 expression after radiation in breast carcinomas cells. And the effects of Herceptin, AG825 and Cisplatin on the expression of nuclear ERBB2 were investigated. Survival fractions were also observed. After radiation, compared with control group, confocal microscopy and Western blot revealed that the expression of nuclear ERBB2 was increased in breast cancer cells time-dependently. Herceptin, and AG825 could significantly inhibit the radiation-induced nuclear ERBB2 expression, and decrease survival fractions. Cisplatin also induced the nuclear ERBB2 expression in breast cancer cells with high ERBB2 expression. It was concluded that radiation could induce ERBB2 nuclear transport, and nuclear ERBB2 may correlate with radiation resistance in breast cancer cells with high ERBB2 expression.
Author 罗波 于世英 庄亮 夏曙 赵臻 荣磊
AuthorAffiliation Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China
AuthorAffiliation_xml – name: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China
Author_xml – sequence: 1
  fullname: 罗波 于世英 庄亮 夏曙 赵臻 荣磊
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19513620$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v3CAQhlGVqvlof0AvldVLD5EbYGywj91VkkaNUinaOxowbL3xwgZsNfn3IfG2lXrICSSeZ2Z455gc-OAtIR8Z_coolWeJsboVJaVtSYHJsnlDjljbQsmg5gf5LiQvqQQ4JMcpbSitpeDVO3LI2pqB4PSI_Ljy3WTGPvgiuOL8drHgxc1kBouxWEX0aRfiWKAbbSxusevxBe19sYgW01gs0Zv8tLTDkN6Ttw6HZD_szxOyujhfLb-X1z8vr5bfrktTUTGWtpKca11ryRsttEO03DS8Bo0aa8fBaAlCSwuIThjNoXONZlC5Bp0WcEJO57K_0Tv0a7UJU_S5oRo3j3fdw4NWludMKFAmM_1lpncx3E82jWrbJ5PHRW_DlFROh3MQssrkpz056a3t1C72W4yP6k9YGZAzYGJIKVqnTD--BDJG7AfFqHpei5rXovII6nktqskm-8_8W_wVh89Oyqxf2_jvn69Jn_eNfgW_vs-e0mjuXD9YBaziFRcATyzGqX4
CitedBy_id crossref_primary_10_1016_j_prro_2014_06_006
crossref_primary_10_1016_j_canlet_2012_01_011
crossref_primary_10_3390_ijms22020747
crossref_primary_10_1080_0284186X_2019_1695061
crossref_primary_10_1007_s11596_012_1053_z
Cites_doi 10.1124/mi.5.1.5
10.1083/jcb.200109033
10.1667/RR1472.1
10.1016/S0955-0674(03)00015-2
10.1074/jbc.273.3.1568
10.1016/0046-8177(90)90227-V
10.1016/j.ygyno.2005.05.045
10.1016/j.ccr.2004.07.012
10.1016/j.cellsig.2006.03.010
10.1002/hep.1840130104
10.1007/s10549-005-9011-0
10.1016/j.clon.2007.03.010
10.1002/glia.10311
10.1038/sj.onc.1208332
10.1080/09553000802641185
10.1677/ERC-07-0240
10.1074/jbc.M506591200
10.1158/0008-5472.338.65.1
10.1016/j.ijrobp.2003.09.093
10.1002/mc.20504
ClassificationCodes R5
ContentType Journal Article
Copyright Huazhong University of Science and Technology and Springer-Verlag GmbH 2009
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Huazhong University of Science and Technology and Springer-Verlag GmbH 2009
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/s11596-009-0317-8
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Induction of ERBB2 Nuclear Transport after Radiation in Breast Cancer Cells
EISSN 1993-1352
EndPage 353
ExternalDocumentID tjykdxxb_e200903017
19513620
10_1007_s11596_009_0317_8
31424263
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: 国家自然科学基金
  funderid: (30672426)
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2JN
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
H13
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IPNFZ
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TGQ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
ABJNI
ABQSL
DPUIP
AAYXX
ADHKG
AGQPQ
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
4A8
93N
PSX
ID FETCH-LOGICAL-c406t-e4722bb5b728b6bfaae2c8253baba5f23cb736b7e3aaf6cb23df8b134f8afb63
IEDL.DBID AGYKE
ISSN 1672-0733
IngestDate Thu May 29 04:06:47 EDT 2025
Fri Sep 05 08:13:23 EDT 2025
Thu Jan 02 22:02:53 EST 2025
Tue Aug 05 11:58:51 EDT 2025
Thu Apr 24 22:58:46 EDT 2025
Fri Feb 21 02:37:18 EST 2025
Fri Nov 25 19:42:25 EST 2022
IsPeerReviewed false
IsScholarly false
Issue 3
Keywords c-ERBB-2
breast cancer
radiosensitivity
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c406t-e4722bb5b728b6bfaae2c8253baba5f23cb736b7e3aaf6cb23df8b134f8afb63
Notes R737.9
c-ERBB-2
c-ERBB-2; breast cancer; radiosensitivity.
breast cancer
42-1679/R
radiosensitivity.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19513620
PQID 733223674
PQPubID 23479
PageCount 4
ParticipantIDs wanfang_journals_tjykdxxb_e200903017
proquest_miscellaneous_733223674
pubmed_primary_19513620
crossref_citationtrail_10_1007_s11596_009_0317_8
crossref_primary_10_1007_s11596_009_0317_8
springer_journals_10_1007_s11596_009_0317_8
chongqing_backfile_31424263
PublicationCentury 2000
PublicationDate 2009-06-01
PublicationDateYYYYMMDD 2009-06-01
PublicationDate_xml – month: 06
  year: 2009
  text: 2009-06-01
  day: 01
PublicationDecade 2000
PublicationPlace Heidelberg
PublicationPlace_xml – name: Heidelberg
– name: China
PublicationSubtitle Medical Sciences
PublicationTitle Journal of Huazhong University of Science and Technology. Medical sciences
PublicationTitleAbbrev J. Huazhong Univ. Sci. Technol. [Med. Sci.]
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Edition
PublicationTitle_FL JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY(MEDICAL SCIENCE)
PublicationYear 2009
Publisher Huazhong University of Science and Technology
Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China
Publisher_xml – name: Huazhong University of Science and Technology
– name: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China
References Offterdinger, Schofer, Weipoltshammer (CR12) 2002; 157
Kamio, Shigematsu, Sou (CR6) 1990; 21
Carpenter (CR10) 2003; 15
Lee, Shrieve, Zempolich (CR16) 2005; 99
Chung, Broaddus (CR2) 2005; 5
Lo, Hsu, Hung (CR3) 2006; 95
Liang, Lu, Jin (CR17) 2003; 2
Marti, Burwen, Wells (CR7) 1991; 13
Wang, Lien, Xia (CR13) 2004; 6
CR11
Irena (CR4) 2006; 18
Lo, Xia, Wei (CR8) 2005; 65
Cao, Li, Wang (CR19) 2009; 171
Dittmann, Mayer, Fehrenbacher (CR14) 2005; 280
Wardman (CR1) 2007; 19
Mass (CR5) 2004; 58
Bandyopadhyay, Mandal, Adam (CR15) 1998; 273
Pancholi, Lykkesfeldt, Hilmi (CR18) 2008; 15
Raabe, Deadwyler, Varga (CR9) 2004; 45
Sasaki (CR20) 2009; 85
Collis, DeWeese, Jeggo (CR21) 2005; 24
R.D. Mass (317_CR5) 2004; 58
T.D. Raabe (317_CR9) 2004; 45
S.J. Collis (317_CR21) 2005; 24
H.W. Lo (317_CR3) 2006; 95
H.W. Lo (317_CR8) 2005; 65
G. Carpenter (317_CR10) 2003; 15
C.M. Lee (317_CR16) 2005; 99
N. Cao (317_CR19) 2009; 171
T. Kamio (317_CR6) 1990; 21
M. Offterdinger (317_CR12) 2002; 157
U. Marti (317_CR7) 1991; 13
S. Irena (317_CR4) 2006; 18
S.C. Wang (317_CR13) 2004; 6
K. Dittmann (317_CR14) 2005; 280
M.S. Sasaki (317_CR20) 2009; 85
T.D. Chung (317_CR2) 2005; 5
S. Pancholi (317_CR18) 2008; 15
P. Wardman (317_CR1) 2007; 19
317_CR11
K. Liang (317_CR17) 2003; 2
D. Bandyopadhyay (317_CR15) 1998; 273
15380516 - Cancer Cell. 2004 Sep;6(3):251-61
15731501 - Mol Interv. 2005 Feb;5(1):15-9
2312105 - Hum Pathol. 1990 Mar;21(3):277-82
17478086 - Clin Oncol (R Coll Radiol). 2007 Aug;19(6):397-417
19138055 - Radiat Res. 2009 Jan;171(1):9-21
14617784 - Mol Cancer Ther. 2003 Nov;2(11):1113-20
16261406 - Breast Cancer Res Treat. 2006 Feb;95(3):211-8
16157365 - Gynecol Oncol. 2005 Nov;99(2):415-21
14967453 - Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):932-40
12648669 - Curr Opin Cell Biol. 2003 Apr;15(2):143-8
15665312 - Cancer Res. 2005 Jan 1;65(1):338-48
15592499 - Oncogene. 2005 Feb 3;24(6):949-61
19205983 - Int J Radiat Biol. 2009 Jan;85(1):26-47
18824559 - Endocr Relat Cancer. 2008 Dec;15(4):985-1002
16713182 - Cell Signal. 2006 Oct;18(10):1537-48
1988335 - Hepatology. 1991 Jan;13(1):15-20
9430697 - J Biol Chem. 1998 Jan 16;273(3):1568-73
14730713 - Glia. 2004 Jan 15;45(2):197-207
12045181 - J Cell Biol. 2002 Jun 10;157(6):929-39
19058255 - Mol Carcinog. 2009 Jul;48(7):610-7
16000298 - J Biol Chem. 2005 Sep 2;280(35):31182-9
References_xml – volume: 5
  start-page: 15
  issue: 1
  year: 2005
  end-page: 19
  ident: CR2
  article-title: Molecular targeting in radiotherapy: Epidermal growth factor receptor
  publication-title: Mol Interv
  doi: 10.1124/mi.5.1.5
– volume: 65
  start-page: 338
  year: 2005
  end-page: 348
  ident: CR8
  article-title: Novel prognostic value of nuclear EGF receptor in breast cancer
  publication-title: Cancer Res
– volume: 157
  start-page: 929
  year: 2002
  end-page: 939
  ident: CR12
  article-title: C-erbB-3: a nuclear protein in mammary epithelial cells
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200109033
– volume: 171
  start-page: 9
  issue: 1
  year: 2009
  end-page: 21
  ident: CR19
  article-title: NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance
  publication-title: Radiat Res
  doi: 10.1667/RR1472.1
– volume: 15
  start-page: 143
  issue: 2
  year: 2003
  end-page: 148
  ident: CR10
  article-title: Nuclear localization and possible functions of receptor tyrosine kinases
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/S0955-0674(03)00015-2
– volume: 58
  start-page: 932
  issue: 3
  year: 2004
  end-page: 940
  ident: CR5
  article-title: The HER receptor family: a rich target for therapeutic development
  publication-title: Int J Radiation Oncology Biol Phys
– volume: 273
  start-page: 1568
  issue: 3
  year: 1998
  end-page: 1573
  ident: CR15
  article-title: Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.273.3.1568
– volume: 21
  start-page: 277
  year: 1990
  end-page: 282
  ident: CR6
  article-title: Immunohistochemical expression of epidermal growth factor receptors in human adrenocortical carcinoma
  publication-title: Hum Pathol
  doi: 10.1016/0046-8177(90)90227-V
– volume: 99
  start-page: 415
  issue: 2
  year: 2005
  end-page: 421
  ident: CR16
  article-title: Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2005.05.045
– volume: 6
  start-page: 251
  issue: 3
  year: 2004
  end-page: 261
  ident: CR13
  article-title: Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2004.07.012
– volume: 18
  start-page: 1537
  issue: 10
  year: 2006
  end-page: 1548
  ident: CR4
  article-title: Epidermal growth factor receptor and DNA double strand break repair: The cell’s self-defense
  publication-title: Cell Signall
  doi: 10.1016/j.cellsig.2006.03.010
– ident: CR11
– volume: 2
  start-page: 1113
  issue: 11
  year: 2003
  end-page: 1120
  ident: CR17
  article-title: Sensitization of breast cancer cells to radiation by trastuzumab
  publication-title: Mol Cancer Ther
– volume: 13
  start-page: 15
  year: 1991
  end-page: 20
  ident: CR7
  article-title: Localization of epidermal growth factor receptor in hepatocyte nuclei
  publication-title: Hepatology
  doi: 10.1002/hep.1840130104
– volume: 95
  start-page: 211
  issue: 3
  year: 2006
  end-page: 218
  ident: CR3
  article-title: EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-005-9011-0
– volume: 19
  start-page: 397
  issue: 6
  year: 2007
  end-page: 417
  ident: CR1
  article-title: Chemical radiosensitizers for use in radiotherapy
  publication-title: Clin Oncol
  doi: 10.1016/j.clon.2007.03.010
– volume: 45
  start-page: 197
  year: 2004
  end-page: 207
  ident: CR9
  article-title: Localization of neuregulin isoforms and erbB receptors in myelinating glial cells
  publication-title: Glia
  doi: 10.1002/glia.10311
– volume: 24
  start-page: 949
  issue: 6
  year: 2005
  end-page: 961
  ident: CR21
  article-title: The life and death of DNA-PK
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208332
– volume: 85
  start-page: 26
  issue: 1
  year: 2009
  end-page: 47
  ident: CR20
  article-title: Advances in the biophysical and molecular bases of radiation cytogenetics
  publication-title: Int J Radiat Biol
  doi: 10.1080/09553000802641185
– volume: 15
  start-page: 985
  issue: 4
  year: 2008
  end-page: 1002
  ident: CR18
  article-title: ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2
  publication-title: Endocr Relat Cancer
  doi: 10.1677/ERC-07-0240
– volume: 280
  start-page: 31 182
  issue: 35
  year: 2005
  end-page: 31 189
  ident: CR14
  article-title: Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M506591200
– volume: 171
  start-page: 9
  issue: 1
  year: 2009
  ident: 317_CR19
  publication-title: Radiat Res
  doi: 10.1667/RR1472.1
– volume: 18
  start-page: 1537
  issue: 10
  year: 2006
  ident: 317_CR4
  publication-title: Cell Signall
  doi: 10.1016/j.cellsig.2006.03.010
– volume: 65
  start-page: 338
  year: 2005
  ident: 317_CR8
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.338.65.1
– volume: 13
  start-page: 15
  year: 1991
  ident: 317_CR7
  publication-title: Hepatology
  doi: 10.1002/hep.1840130104
– volume: 15
  start-page: 143
  issue: 2
  year: 2003
  ident: 317_CR10
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/S0955-0674(03)00015-2
– volume: 157
  start-page: 929
  year: 2002
  ident: 317_CR12
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200109033
– volume: 99
  start-page: 415
  issue: 2
  year: 2005
  ident: 317_CR16
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2005.05.045
– volume: 19
  start-page: 397
  issue: 6
  year: 2007
  ident: 317_CR1
  publication-title: Clin Oncol
  doi: 10.1016/j.clon.2007.03.010
– volume: 95
  start-page: 211
  issue: 3
  year: 2006
  ident: 317_CR3
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-005-9011-0
– volume: 5
  start-page: 15
  issue: 1
  year: 2005
  ident: 317_CR2
  publication-title: Mol Interv
  doi: 10.1124/mi.5.1.5
– volume: 58
  start-page: 932
  issue: 3
  year: 2004
  ident: 317_CR5
  publication-title: Int J Radiation Oncology Biol Phys
  doi: 10.1016/j.ijrobp.2003.09.093
– ident: 317_CR11
  doi: 10.1002/mc.20504
– volume: 280
  start-page: 31 182
  issue: 35
  year: 2005
  ident: 317_CR14
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M506591200
– volume: 273
  start-page: 1568
  issue: 3
  year: 1998
  ident: 317_CR15
  publication-title: J Biol Chem
  doi: 10.1074/jbc.273.3.1568
– volume: 85
  start-page: 26
  issue: 1
  year: 2009
  ident: 317_CR20
  publication-title: Int J Radiat Biol
  doi: 10.1080/09553000802641185
– volume: 6
  start-page: 251
  issue: 3
  year: 2004
  ident: 317_CR13
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2004.07.012
– volume: 2
  start-page: 1113
  issue: 11
  year: 2003
  ident: 317_CR17
  publication-title: Mol Cancer Ther
– volume: 24
  start-page: 949
  issue: 6
  year: 2005
  ident: 317_CR21
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208332
– volume: 21
  start-page: 277
  year: 1990
  ident: 317_CR6
  publication-title: Hum Pathol
  doi: 10.1016/0046-8177(90)90227-V
– volume: 45
  start-page: 197
  year: 2004
  ident: 317_CR9
  publication-title: Glia
  doi: 10.1002/glia.10311
– volume: 15
  start-page: 985
  issue: 4
  year: 2008
  ident: 317_CR18
  publication-title: Endocr Relat Cancer
  doi: 10.1677/ERC-07-0240
– reference: 15731501 - Mol Interv. 2005 Feb;5(1):15-9
– reference: 16000298 - J Biol Chem. 2005 Sep 2;280(35):31182-9
– reference: 16713182 - Cell Signal. 2006 Oct;18(10):1537-48
– reference: 19138055 - Radiat Res. 2009 Jan;171(1):9-21
– reference: 19058255 - Mol Carcinog. 2009 Jul;48(7):610-7
– reference: 15380516 - Cancer Cell. 2004 Sep;6(3):251-61
– reference: 14730713 - Glia. 2004 Jan 15;45(2):197-207
– reference: 18824559 - Endocr Relat Cancer. 2008 Dec;15(4):985-1002
– reference: 17478086 - Clin Oncol (R Coll Radiol). 2007 Aug;19(6):397-417
– reference: 14967453 - Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):932-40
– reference: 1988335 - Hepatology. 1991 Jan;13(1):15-20
– reference: 9430697 - J Biol Chem. 1998 Jan 16;273(3):1568-73
– reference: 15665312 - Cancer Res. 2005 Jan 1;65(1):338-48
– reference: 16157365 - Gynecol Oncol. 2005 Nov;99(2):415-21
– reference: 12648669 - Curr Opin Cell Biol. 2003 Apr;15(2):143-8
– reference: 16261406 - Breast Cancer Res Treat. 2006 Feb;95(3):211-8
– reference: 12045181 - J Cell Biol. 2002 Jun 10;157(6):929-39
– reference: 19205983 - Int J Radiat Biol. 2009 Jan;85(1):26-47
– reference: 2312105 - Hum Pathol. 1990 Mar;21(3):277-82
– reference: 15592499 - Oncogene. 2005 Feb 3;24(6):949-61
– reference: 14617784 - Mol Cancer Ther. 2003 Nov;2(11):1113-20
SSID ssj0057624
Score 1.4825794
Snippet The ERBB2 nuclear transport in breast cancer cell lines after radiation and its possible role in radiation tolerance were observed. Confocal microscopy and...
Summary The ERBB2 nuclear transport in breast cancer cell lines after radiation and its possible role in radiation tolerance were observed. Confocal microscopy...
R5; ex-pression in breast cancer cells with high ERBB2 expression. It was concluded that radiation could induce ERBB2 nuclear transport, and nuclear ERBB2 may...
SourceID wanfang
proquest
pubmed
crossref
springer
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 350
SubjectTerms Active Transport, Cell Nucleus - radiation effects
Antibodies, Monoclonal - pharmacology
Antibodies, Monoclonal, Humanized
Benzothiazoles - pharmacology
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Breast Neoplasms - radiotherapy
Cell Line, Tumor
Cell Nucleus - metabolism
Cisplatin - pharmacology
Female
Humans
Medicine
Medicine & Public Health
Nuclear Pore - metabolism
Protein Transport - radiation effects
Radiation Tolerance - genetics
Receptor, ErbB-2 - genetics
Receptor, ErbB-2 - metabolism
Receptor, ErbB-2 - radiation effects
Trastuzumab
Tyrphostins - pharmacology
乳腺癌
癌细胞
Title Induction of ERBB2 Nuclear Transport after Radiation in Breast Cancer Cells
URI http://lib.cqvip.com/qk/85740A/20093/31424263.html
https://link.springer.com/article/10.1007/s11596-009-0317-8
https://www.ncbi.nlm.nih.gov/pubmed/19513620
https://www.proquest.com/docview/733223674
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e200903017
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LTxwxDLbKIlW9lL470KIcOLUaNJNkXscFLUVF9FAtEj1FcSaBdqtsuzsr0f564nmw9CEk7plEYzt-xPZngD0npckrmcSmSMpYWidjbWseJzXHrHZWJJaeBk4_5cdn8uN5dt73cS-HavchJdlq6nWzW7C8Ifqlx3xBqnUDNrO0rMoRbI4_fDmZDAo4eNDdLNu8oMJKIYZk5v82IUiFy7m_-BkO_NM0_eNv3sqVth0-3ml_ccsYHW3BdPiNrgZltr9qcN_8_gvh8Z7_-QQe984pG3fS9BQeWP8MHp726ffncEKDPtpGCDZ3bPL54IAzT4DIesGaASWdtWPH2YJAD9qlXz1DKn1vmCERWzBKFixfwPRoMj08jvtpDLEJRr-JLcFKImZY8BJzdFpbbkJ8KVCjzhwXBguRY2GF1i43yEXtSkyFdKV2mIuXMPJzb18Dq6ysEpfW2gopLee6FCmmqAs0VR0inAh2bngSjLmZEUSVEtSTx3MRQTJwSZkex5zGaXxXawRmoqAKFFREQVVG8O7mkx8diMddi9nAehWuGpFEeztfLVUQJU6AdzKCV51IrHcLjmpwBZII3g9MVb0yWN511F4vRuvFzbdfs_rqCpWlvBUFrMX2vTbdgUddxoteit7AqFms7NvgODW421-UXdg44-Nr47gN5A
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LTxsxEB5BKkEvqKWFLrTgA6dWK21sZ3dzDAiUAuGAgsTN8nhtHqmckiwS_Hs8-yBUVEjcx7bkz_a8PN8A7DkpTdqXSWyyJI-ldTLWtuBxUnDsFc6KxFJoYHSWDi_k8WXvsqnjnre_3duUZPVSL4rdguYN3i8F8wU9rcvwIdgCObUtuOCD9vkN9nPdyTbN6FulEG0q839TEKHC9dRf3YXl_lVMr6zNF5nSqr7HO-2vXqiio0-w1tiQbFCD_hmWrF-HlVGTJf8CJ9SPo6pXYFPHDs_39znzxFusZ6xsycxZ1R2czYiboBK98Qzph3rJDJ2EGaOY_vwrjI8OxwfDuGmaEJugm8vYEvsjYg8znmOKTmvLTXADBWrUPceFwUykmFmhtUsNclG4HLtCulw7TMUGdPzU22_A-lb2E9cttBVSWs51LrrYRZ2h6RfBEYlg-3nzgs41E2KSUoJK53gqIkja7VSmoRunrhd_1IIomdBQAQ1FaKg8gp_PQ_7WXBtvCbMWIxVuBG2J9nZ6P1cBc068dDKCzRq7xWzBngwaO4ngVwumau7s_K2l9hq8F8Ll7eOkeHhAZSm9RH5ltvWuSXdhdTgenarT32cn2_CxTlJRcOc7dMrZvf0RbJ0Sd6qz_QRgkfMA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB4VKqFeUEuhBCj4wIkqIrG9SfbIawWloAqBxM3yOPa2gLywGyT67_HkwYKKkLj7Ifkbe16ebwA2nZQm68skNnlSxNI6GWtb8jgpOfZKZ0ViKTRwcpodXsifl73Lts_ppPvt3qUkm5oGYmny1fZt6banhW9BCwdPmAL7gp7ZGfgYXuOUBP2C73RPcbClm662WU5fLIXo0pqvLUHkCn9GfngXtn6ppP6zPJ9lTetaH--0Hz5TS4PPMN_ak2ynEYAv8MH6BZg7aTPmX-GYenPUtQts5NjB2e4uZ544jPWYVR2xOas7hbMx8RTUQ_96hvRbvWKGpGLMKL4_WYTzwcH53mHcNlCITdDTVWyJCRKxhzkvMEOnteUmuIQCNeqe48JgLjLMrdDaZQa5KF2BqZCu0A4zsQSzfuTtMrC-lf3EpaW2QkrLuS5EiinqHE2_DE5JBKtPhxf0r7kmViklqIyOZyKCpDtOZVrqceqAcaOmpMmEhgpoKEJDFRFsPU25bXg33hrMOoxUuB10JNrb0f1EBcw5cdTJCL412E1XC7Zl0N5JBD86MFV7fydvbbXZ4j0dXF39uy4fHlBZSjWRj5mvvGvRDZj7vT9Qv45Oj1fhU5OvojjPGsxW43v7PZg9Fa7Xov0IbJH3PA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Induction+of+ERBB2+Nuclear+Transport+after+Radiation+in+Breast+Cancer+Cells&rft.jtitle=%E5%8D%8E%E4%B8%AD%E7%A7%91%E6%8A%80%E5%A4%A7%E5%AD%A6%E5%AD%A6%E6%8A%A5%EF%BC%88%E5%8C%BB%E5%AD%A6%EF%BC%89%EF%BC%88%E8%8B%B1%E5%BE%B7%E6%96%87%E7%89%88%EF%BC%89&rft.au=Bo+LUO&rft.au=Shiying+YU&rft.au=Liang+ZHUANG&rft.au=Shu+XIA&rft.date=2009-06-01&rft.pub=Department+of+Oncology%2C+Tongji+Hospital%2C+Tongji+Medical+College%2C+Huazhong+University+of+Science+and+Technology%2C+Wuhan+430030%2CChina&rft.issn=1672-0733&rft.volume=29&rft.issue=3&rft.spage=350&rft.epage=353&rft_id=info:doi/10.1007%2Fs11596-009-0317-8&rft.externalDocID=tjykdxxb_e200903017
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg